TY - JOUR
T1 - Rotavirus vaccines: considerations for successful implementation in Europe
AU - van Damme, Pierre
AU - van der Wielen, Marie
AU - Ansaldi, Filippo
AU - Desgrandchamps, Daniel
AU - Domingo, Javier Diez
AU - Sanchez, Francisco Gimenez
AU - Gray, James
AU - Haditsch, Martin
AU - Johansen, Kari
AU - Lorgelly, Paula
AU - Lorrot, Mathie
AU - Parez, Nathalie
AU - Reschke, Volkmar
AU - Rose, Markus
PY - 2006
Y1 - 2006
N2 - A group of European experts in infectious diseases and vaccinology has met on several occasions to assess the rationale for universal vaccination against rotavirus infection of infants in Europe. On the basis of the available data, we concluded that vaccination was the best approach to prevent severe rotavirus gastroenteritis, and that European countries should consider implementing rotavirus vaccination in their routine immunisation programmes. The main barrier to the implementation of rotavirus vaccination in Europe is a general lack of awareness of stakeholders, policymakers, health-care professionals, and parents about rotavirus disease and the advantages of vaccination. Further studies on the cost of the disease and the benefit of vaccination, together with raising awareness are necessary steps to ensure successful implementation of rotavirus vaccination in Europe.
AB - A group of European experts in infectious diseases and vaccinology has met on several occasions to assess the rationale for universal vaccination against rotavirus infection of infants in Europe. On the basis of the available data, we concluded that vaccination was the best approach to prevent severe rotavirus gastroenteritis, and that European countries should consider implementing rotavirus vaccination in their routine immunisation programmes. The main barrier to the implementation of rotavirus vaccination in Europe is a general lack of awareness of stakeholders, policymakers, health-care professionals, and parents about rotavirus disease and the advantages of vaccination. Further studies on the cost of the disease and the benefit of vaccination, together with raising awareness are necessary steps to ensure successful implementation of rotavirus vaccination in Europe.
U2 - 10.1016/S1473-3099(06)70657-0
DO - 10.1016/S1473-3099(06)70657-0
M3 - Article
VL - 6
SP - 805
EP - 812
JO - The Lancet Infectious Diseases
JF - The Lancet Infectious Diseases
SN - 1473-3099
IS - 12
ER -